Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Mastech Digital Beats Q2 Earnings ViewsPhoto, wide shot, wide-angle lens,  Retail store, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/add1012b-1b24-4eb2-aba0-77ab52c7f8ad.png
Mastech Digital Beats Q2 Earnings Views

Mastech Digital (NYSEMKT:MHH), a provider of IT staffing and digital transformation services, reported its results for Q2 2025 on August 13, 2025. The standout news from the release was an earnings

AMD's Earnings Miss Doesn't Matter: This Is Much More ImportantPhoto, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
AMD's Earnings Miss Doesn't Matter: This Is Much More Important

The market can oftentimes focus too much on companies' short-term results. Whether a company meets, beats, or misses expectations for a given quarter, the results can be a notable spike or slide in

BeyondSpring Cash Jumps in Fiscal Q2Photo, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
BeyondSpring Cash Jumps in Fiscal Q2

BeyondSpring (NASDAQ:BYSI), a clinical-stage biotechnology company developing innovative cancer therapies, released its second quarter 2025 results on August 13, 2025. The headline news is a

Moleculin Biotech Misses Fiscal Q2 EPS
Moleculin Biotech Misses Fiscal Q2 EPS

Moleculin Biotech (NASDAQ:MBRX), a clinical-stage pharmaceutical developer focused on oncology, released its second quarter 2025 results on August 13, 2025.

The biggest news from this update was a

VerifyMe Beats Q2 Loss Revenue Drops 16%
VerifyMe Beats Q2 Loss Revenue Drops 16%

VerifyMe (NASDAQ:VRME), a provider of logistics technology and authentication solutions for high-value and sensitive shipments, reported second quarter results on August 13, 2025. The company posted

LUCD Reports Results
LUCD Reports Results

Lucid Diagnostics (NASDAQ:LUCD), a diagnostics company focused on non-invasive detection of esophageal precancer and cancer, released its second quarter 2025 earnings results on August 13, 2025

Indaptus Posts Narrower Loss in Q2Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
Indaptus Posts Narrower Loss in Q2

Indaptus Therapeutics (NASDAQ:INDP), a biotechnology company advancing a novel immunotherapy platform for cancer and infectious diseases, reported its second quarter earnings on August 13, 2025. The

XRP Just Passed $3. Is $4 on the Horizon?
XRP Just Passed $3. Is $4 on the Horizon?

XRP (CRYPTO: XRP), the world's third-largest cryptocurrency, which has a market cap over $177 billion, recently passed $3. While the cryptocurrency continues to be volatile, XRP has had an epic run

XOMA Revenue Jumps 39% in Fiscal Q2Photo, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
XOMA Revenue Jumps 39% in Fiscal Q2

XOMA (NASDAQ:XOMA), a biotechnology royalty aggregator, reported second quarter results on August 13, 2025, for the period ending June 30. The company’s revenue (GAAP) reached $13.1 million for Q2

D-Wave Quantum vs. IonQ: Which is the Better Quantum Computing Stock?
D-Wave Quantum vs. IonQ: Which is the Better Quantum Computing Stock?

Quantum computing stocks are absolutely sizzling right now. Over the last year, two companies that have emerged as frontrunners in the quantum computing revolution are IonQ (NYSE: IONQ) and D-Wave

Madison Square Garden Beats Q4 RevenuePhoto, wide shot, wide-angle lens,  Cloud computing provider, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/8d7b6619-8b3b-4e9e-b659-68643d72528e.png
Madison Square Garden Beats Q4 Revenue

Madison Square Garden Entertainment (NYSE:MSGE), the owner and operator of iconic live entertainment venues, released its Q4 FY2025 earnings on August 13, 2025. The main headlines from the release

Could Ethereum Hit $5,000 Before 2026?
Could Ethereum Hit $5,000 Before 2026?

Great investing often comes down to asking simple questions at the right time. Today's biggest questions about Ethereum (CRYPTO: ETH) are whether it can surpass the $5,000 level and, more

Adaptimmune Sales Jump 59 PercentPhoto, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
Adaptimmune Sales Jump 59 Percent

Adaptimmune Therapeutics Plc (NASDAQ:ADAP), a biotechnology company specializing in engineered T-cell therapies for cancer, released its second-quarter earnings on August 13, 2025, covering results

Sagimet Biosciences Tops Q2 EPS ForecastPhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Sagimet Biosciences Tops Q2 EPS Forecast

Sagimet Biosciences (NASDAQ:SGMT), a clinical-stage biotechnology developer focused on fatty acid synthase (FASN) inhibitors, delivered its second-quarter results on August 13, 2025. The most

Mesa Air Posts Profit in Fiscal Q3Photo, wide shot, wide-angle lens,  Heavy machinery, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/c15253b0-7330-4605-a666-66954eaf6715.png
Mesa Air Posts Profit in Fiscal Q3

Mesa Air Group (NASDAQ:MESA), a regional airline operating primarily under capacity purchase agreements for major U.S. carriers, released its third-quarter fiscal 2025 results on August 13, 2025

Local Bounti Posts 28% Sales Gain in Q2
Local Bounti Posts 28% Sales Gain in Q2

Local Bounti (NYSE:LOCL), a controlled environment agriculture company specializing in sustainably grown produce, reported its second quarter 2025 earnings on August 13, 2025. The most significant

Prediction: This Artificial Intelligence (AI) Stock Will Outperform Nvidia Through 2030Photo, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
Prediction: This Artificial Intelligence (AI) Stock Will Outperform Nvidia Through 2030

If you look back at the past couple of years, there's arguably no stock that has received as much attention as Nvidia (NASDAQ: NVDA). The current artificial intelligence (AI) boom has propelled

Is This Underrated Artificial Intelligence (AI) Stock the Next Big Winner?Photo, wide shot, wide-angle lens,  Data analytics provider, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/d1295d04-cceb-4f1c-be2b-32ca46621336.png
Is This Underrated Artificial Intelligence (AI) Stock the Next Big Winner?

Investors are getting to know artificial intelligence (AI) infrastructure company Nebius Group (NASDAQ: NBIS). It's been somewhat under the radar until Nebius recently released its second-quarter

Sbc Medical Group Posts Weak Fiscal Q2
Sbc Medical Group Posts Weak Fiscal Q2

Sbc Medical Group (NASDAQ:SBC), a provider of cosmetic and medical services with a broad franchise and technology platform, released its earnings for the second quarter of fiscal 2025 on August 13

The Smartest Energy Stocks to Buy With $1,000 Right NowPhoto, wide shot, wide-angle lens,  Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.midjourneyapi.xyz/temp/138548fd-aba2-4b3e-b9ee-93725b372952.png
The Smartest Energy Stocks to Buy With $1,000 Right Now

Energy of all kinds is vital to modern life. But the world doesn't sit still, either, and the types of energy that the world demands are starting to change. Although an all-of-the-above strategy is

Mersana Misses Fiscal Q2 Revenue TargetPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Mersana Misses Fiscal Q2 Revenue Target

Mersana Therapeutics (NASDAQ:MRSN), a clinical-stage biotech specializing in antibody-drug conjugates (ADCs) for cancer, reported its second quarter results on August 13, 2025. The company’s update

Tourmaline Bio Reports Loss as R&D RisesPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Tourmaline Bio Reports Loss as R&D Rises

Tourmaline Bio (NASDAQ:TRML), a clinical-stage biotechnology company focusing on treatments for inflammatory diseases, published its earnings for the second quarter on August 13, 2025. The most

Sanara MedTech Sales Jump 28 Percent
Sanara MedTech Sales Jump 28 Percent

Sanara MedTech (NASDAQ:SMTI), a developer of surgical wound care products and value-based care technology, reported its Q2 FY2025 earnings on August 13, 2025. The report showed the company’s GAAP

PDSB Loss Improves as Costs DropPhoto, wide shot, wide-angle lens,  Coal company, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/0e838f13-fa33-4583-92e9-bf3375dacf70.png
PDSB Loss Improves as Costs Drop

PDS Biotechnology (NASDAQ:PDSB), a clinical-stage immunotherapy company focused on innovative oncology and infectious disease solutions, released its second quarter results on August 13, 2025, for

Will Starlink SPAC or IPO in 2025?Photo, wide shot, wide-angle lens, soft focus,  Car rental company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-C39HK7mRtkD4E8dIGhNKdJKJ.png?st=2023-05-14T13%3A30%3A04Z&se=2023-05-14T15%3A30%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-13T20%3A57%3A44Z&ske=2023-05-14T20%3A57%3A44Z&sks=b&skv=2021-08-06&sig=c7kEiWtHt1KibrlL7jP9uEmEuV%2BuAnv1nRBACXoedSk%3D
Will Starlink SPAC or IPO in 2025?

For years, many investors have been waiting to get a piece of SpaceX, the massive space exploration company led by Tesla (NASDAQ: TSLA) CEO Elon Musk. According to most lists, SpaceX is the most